Senate questions CDC nominee Schwartz on vaccine policy amid ties to Robert F. Kennedy Jr.

Sean Kaufman, Schwartz’s fellow nominee for the Administration for Strategic Preparedness, has publicly criticized COVID-19 vaccines and infant Hepatitis B vaccines, prompting senators to question his commitment to vaccines as a public health tool.
Sen. Cassidy warned that any equivocation on vaccine policy could cost Schwartz’s nomination, stating, 'Any equivocation on these facts, and I shall not be able to support your immunization, your nomination, because when trust is destroyed, it’s hard to be effective.'
Public trust in the CDC has declined sharply, with a June poll showing only about 50% of Americans trusting the agency’s health recommendations, down from 77% in spring 2025.
The CDC continues to grapple with turnover, having lost more than 3,000 employees (more than a quarter of its workforce) amid morale problems and a wave of political appointees filling leadership roles.
Local public health leaders describe a perception that the CDC is no longer the sole authoritative lead on outbreaks, with remarks like 'There’s still really good people who work there... they are navigating choppy waters' and concerns that leadership turnover has left the agency adrift.
Senate lawmakers grilled Dr. Erica Schwartz during her confirmation hearing to lead the CDC, pressing her on whether she would push back against Health Secretary Robert F. Kennedy Jr.'s well-known anti-vaccine views Washington Examiner. Schwartz, a former Coast Guard officer and deputy surgeon general, defended her commitment to science — but senators from both parties made clear that vaccine policy would define her confirmation.
The hearing comes as the CDC struggles with a crisis of its own. The agency has lost more than 3,000 employees — over a quarter of its workforce — amid low morale and a flood of political appointees in leadership roles The News Tribune.
Sen. Bill Cassidy delivered the sharpest warning of the hearing. He told Schwartz directly: 'Any equivocation on these facts, and I shall not be able to support your nomination, because when trust is destroyed, it's hard to be effective' Island Packet. The Republican senator, himself a physician, made clear he expected a firm commitment to vaccine science — not political hedging.
Schwartz's fellow nominee, Sean Kaufman, drew heavy fire as well. Kaufman, nominated to lead the Administration for Strategic Preparedness, has publicly criticized COVID-19 vaccines and infant Hepatitis B vaccines Washington Examiner. Senators from both parties questioned whether he sees vaccines as a core public health tool at all.
Kennedy oversees the CDC as Health and Human Services Secretary. He has spent decades spreading doubt about vaccine safety. That makes his influence over Schwartz a central concern for lawmakers Newsmax. If she follows his lead, senators warned, the agency's ability to fight disease outbreaks could collapse.
Schwartz tried to distance herself from Kennedy's views. She pointed to her military medical background and said she would follow the data. But critics noted she would still report to Kennedy — and that her access to resources, staff, and policy decisions would run through his office Idaho Statesman.
The timing of the hearing is dire for the agency's image. A June poll found that only about 50% of Americans trust the CDC's health recommendations The News Tribune. That is down from 77% just months earlier, in spring 2025. No public health agency can do its job when half the country doesn't believe it.
Local public health leaders paint a grim picture. One official noted, 'There's still really good people who work there... they are navigating choppy waters' Island Packet. The perception on the ground is that the CDC is no longer the clear authority when an outbreak hits.
Supporters argue Schwartz is the right pick to steady a battered agency. Her Coast Guard career gave her experience running large organizations under pressure. Her time as deputy surgeon general means she knows federal health bureaucracy from the inside Newsmax. Backers say that combination could help stop the revolving door of CDC leadership.
Analysts warn, though, that structural problems won't disappear with one new director. The CDC has cycled through leaders since the first Trump term, making consistent public health guidance nearly impossible Washington Examiner. Until staffing stabilizes and political pressure eases, even a strong director faces steep odds.
Publishers
28
Articles
274
Reach
302